Cancer Biomarkers in Body Fluids

• Format: eBook
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine and Nursing; Oncology; anti-GD2; anti-PD-1; ASCT; autoantibodies; autoimmunity; biomarker; biomarkers; bladder cancer; blood biomarkers; breast cancer; breast cancer biomarkers; cancer; cancer biomarkers; cancer development; cancer pathogenesis; cancer progression; cancer susceptibility; ceramide; cerebrospinal fluid; cfDNA; circulating nucleosomes; circulating tumor cells; circulating tumor DNA; colonoscopy; ctDNA; cytokines; diagnosis; diagnostic biomarkers; diagnostics; dinutuximab; disease modelling; DNA; DNA methylation; E7 oncoprotein; early detection; early diagnosis; ELISA; epigenetic biomarkers; epigenetics; exo-oncomiRNAS; exosome; exosomes; extracellular vesicle; extracellular vesicles; fecal immunochemical test (FIT); flexible sigmoidoscopy; gas chromatography (GC); GM-CSF; headspace solid phase microextraction (HS-SPME); hereditary and familial pancreatic cancer; HPV antibodies; HPV DNA; human papillomavirus; IL-2; immune monitoring; immunotherapy; leptomeningeal metastasis; linear discriminant analysis (LDA); lipid; lipidomics; liquid biopsy; lung cancer; machine learning; mass spectrometry (MS); melanoma; metabolic pathways; metabolic signaling; metabolism; metabolomics; micro-RNAs; microRNA; miRNA; miRNAs; molecular composition; molecular pathways; mRNA; n/a; NETs; neuroblastoma; next generation sequencing; oropharyngeal squamous cell carcinoma; outcome; ovarian cancer; patient stratification; personalized medicine; phospholipid; PKC inhibitor; plasma; plasma metabolites; plasmalogen; plasminogen activator inhibitor-1; potentially druggable genes; predictive biomarker; primary breast cancer; principal component analysis (PCA); principal component regression (PCR); prognosis; prognostic biomarker; prostate cancer; proteins; response; rheumatoid factor; RNA sequencing; semen; serum; small non-coding RNA; sncRNA; somatic mutation profiling; therapeutics; treatment; treatment de-escalation; treatment decisions; tumor load; tumor recurrence; TWEAK; urine; urine liquid biopsy; urothelial cancer; uveal melanoma; volatile organic compounds (VOCs)
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication
• Physical Description: 1 online resource (490 p.)
• ISBN: 9783036566481; 9783036566498; books978-3-0365-6648-1
• Access: Open Access

Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.